Importance of sustained high glucose condition in the development of diabetic osteopenia: possible involvement of the polyol pathway

Osteoporos Int. 1997:7 Suppl 3:S209-12. doi: 10.1007/BF03194374.
No abstract available

MeSH terms

  • Aldehyde Reductase / antagonists & inhibitors
  • Animals
  • Bone Density
  • Bone Diseases, Metabolic / etiology*
  • Bone and Bones / drug effects*
  • Bone and Bones / metabolism
  • Calcitriol / pharmacology
  • Cells, Cultured
  • Diabetes Mellitus, Type 2 / complications*
  • Enzyme Inhibitors / pharmacology
  • Galactose / administration & dosage
  • Glucose / pharmacology*
  • Humans
  • Hypercalcemia / complications*
  • Hypoglycemic Agents / therapeutic use
  • Male
  • Middle Aged
  • Osteoblasts / drug effects
  • Parathyroid Hormone / pharmacology
  • Rats

Substances

  • Enzyme Inhibitors
  • Hypoglycemic Agents
  • Parathyroid Hormone
  • Aldehyde Reductase
  • Calcitriol
  • Glucose
  • Galactose